Cincinnati, Ohio; Guangzhou, China: July 25, 2017: CUBD announces the Series A investment by Suzhou based InnoMD MEDICAL
INNOVATION SERVICE COMPANY, LTD. to TearFilm Innovations. InnoMD also intends to license the TearFilm Dry Eye technology and bring to the China market. CUBD team from China and US facilitated the transaction.
Tear Film Innovations (TFI) is an early-stage company developing a family of break-through products for the treatment of evaporative dry eye and related syndromes including meibomian gland dysfunction (MGD) and blepharitis.